11:04 AM EDT, 05/21/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.61% to 1,465.88 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and petroleum refiner Equinor ( EQNR ) , which rose 8.4% and 1.7% respectively. They were followed by biopharmaceutical company argenx (ARGX) and furniture manufacturer Natuzzi (NTZ), which were up 1.6% and 1.5% respectively.

The decliners from continental Europe were led by medical device maker EDAP (EDAP) and biopharmaceutical company DBV Technologies ( DBVT ) , which dropped 4% and 2.2% respectively. They were followed by biotech firm BioNTech (BNTX) and internet advertising company Criteo ( CRTO ) , which fell 2.1% and 1.3% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical companies AstraZeneca ( AZN ) and GSK (GSK), which increased 1.4% and 1.2% respectively. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) and financial services company Lloyds Banking Group ( LYG ) , which advanced 1% and 0.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Biodexa Pharmaceuticals ( BDRX ) , which lost 8.9% and 2.3% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and cruise line operator Carnival (CUK), which were down 1.8% each.